Surface plasmon resonance (SPR) technology has emerged as a new and powerful technique to investigate the interaction between low-molecular-weight molecules and target proteins. In the present work, the authors assemble from a large compound collection a library of 2226 molecules (fragments having low molecular weights between 100 and 300 Da) to screen them for binding to chymase, a serine protease. Both the active chymase and a zymogen-like form of the protein were used in parallel to distinguish between specific and unspecific binding. The relative ligand-binding activity of the immobilized protein was periodically measured with a reference compound. The screening experiments were performed at 25 °C at a fragment concentration of 200 µM in the presence of 2% DMSO. Applying the filter cascade, affinity-selectivity-competition (competition with reference compounds and cross-competition with fragments), 80 compounds show up as positive screening hits. Competition experiments between fragments show that they bind to different parts of the active site. Of 36 fragments cocrystallized for X-ray studies, 12 could be located in the active site of the protein. These results validate the authors' library and demonstrate that the application of SPR technology as a filter in fragment screening can be achieved successfully. (Journal of Biomolecular Screening. 2009:337-349) 
INTRODUCTION
H igh-throughput screening (HTS) is the tool most often used to carry out the search for new chemical compounds serving as lead structures for medicinal chemists. 1 Undoubtedly, there are many successfully performed HTS campaigns. However, the HTS strategy is complex and expensive and has, like every other method, a number of drawbacks that limit the probability of finding new compounds. 2, 3 Therefore, the pharmaceutical industry is permanently exploring complementary and innovative technologies to improve the difficult process of the discovery of small-molecule drug candidates. 4 As one of these alternative methods, fragment-based screening has become a promising technology of pharmaceutical research. 5 Fragment-based screening is aimed at evolving new tight binder molecules in a step-by-step approach and is different from HTS, in which full-size compounds are screened in a 1-step procedure. Fragment-based screening involves the selection, screening, and optimization of so-called fragments. These are small, less complex molecules (sometimes also called scaffolds, needles, shapes, or binding elements) with much lower molecular weights (MW <200 Da) than those typically found in HTS compound collections. 6 The use of such fragments offers a number of attractive features compared with the use of classical compound libraries. Despite their low potency, fragments are always more efficient binders because, due to their lower complexity, they have higher binding energy per unit mass than the HTS hits. Without giving precise numbers, experts agree that a lower number of compounds is needed to fill the chemical space when working with fragments. The probability that fragments match the binding site of a target protein is higher, and it is easier to structurally validate and understand the binding interaction. However, at the end, precise information about the binding mode from X-ray structure analysis is a must for the subsequent chemical optimization process.
This chemical optimization process that comprises development of these fragments into leads and finally into drugs is, as a consequence of affinity enhancement, accompanied by an increase in molecular weight and most often in lipophilicity. The process can be done in several ways. 7 For example, fragments that bind in different parts of the target binding site can be rationally linked, promoted by innovative ideas from medicinal chemists and molecular modelers, to give larger and high-affinity ligands. Alternatively, the binding site can be used to guide self-assembling of fragments containing chemical groups that can react to link the fragments, an approach described as "click chemistry." 8, 9 In a successful optimization process, the anchoring fragments that have been found to interact with the protein via discrete, specific contacts should preserve their binding modes even after linking them together into high-molecular-weight compounds. 5, 10, 11 Special screening methods are generally needed for searching fragment hits because biological functional assays normally fail for compounds of very low affinity. Nuclear magnetic resonance (NMR) screening is one of the most productive fragment-based approaches through which it is possible to identify small-molecule inhibitors for a variety of targets. 10, 11 On one hand, NMR is a beneficial method because it allows extracting structural information on the binding mode of the fragments. 10 On the other hand, the need for a significantly high protein concentration is rather disadvantageous. Moreover, the ligands are often not soluble at the required high concentrations.
Mass spectroscopy is another method to discover weak binding ligands. It can offer the required sensitivity, but costs are high and interfacing problems such as polymer adsorption still have to be resolved satisfactorily. 12 X-ray crystallography can provide the most complete picture of fragment binding to a target. The binding orientation of the molecular fragments as determined in the crystal plays a critical role in guiding efficient lead optimization programs. 13 A drawback of applying X-ray to a fragment library is the low throughput of the technique. To circumvent this disadvantage, X-ray screening and NMR screening are often performed using compound cocktails. 14 The use of surface plasmon resonance (SPR) to screen for fragments has been recently demonstrated. 15, 16 The goal of this work is to present new selection criteria in such screens to reduce the number of false-positives. The use of an appropriate reference protein that enables testing of sitespecific binding is demonstrated. Moreover, competition assays not only help to further reduce the number of false-positive hits but also give additional information of binding to different pockets of the active site.
We looked for fragments that bind in any of the pockets of chymase, a serine protease mainly found in mast cells. 17 Many secreted proteases have a pro-region attached to the N-terminus of the enzymes. Zymogen activation proceeds via proteolytic removal of these pro-regions. We demonstrate with our work that such a zymogen-like form (zymogen) can be used as a reference protein in a fragment screening to address the problem of selectivity of binding. Positive hits were identified according to selection criteria. In a 1st screen, these criteria were based on affinity and selectivity. The selectivity criterion was related to the binding of the compounds to the zymogen and to the active protein. The affinity filter was set to 3 times the noise level determined via standard deviation of negative controls. Compounds that were selected as positives in the 1st screen were further characterized by competition experiments using well-known inhibitors occupying most parts of the active site. Cross-competition of fragments indicated whether 2 given fragments bound to the same or different pockets in the active site. Finally, the fragment hits were also submitted for X-ray crystal structure determination.
MATERIALS AND METHODS

Instruments
Binding experiments were performed on a S51 Biacore instrument. The fragment solutions were prepared on a TECAN Genesis RSP 100 robot. Fluorescence measurements were performed on an SLM-AMINCO 8100 double-grating spectrofluorometer.
Proteins
The synthetically made gene for chymase was purchased from GenScript Corp. (Piscataway, NJ). Chymase was cloned into the pET21a vector in a similar way as described by Takai and others. 18 The recombinant human chymase was expressed in BL21 (DE3) cells as an N-terminal fusion protein with a 19-aminoacid polypeptide carrying a 6xHis tag and a enterokinase cleavage site. Because the protein was expressed forming insoluble inclusion bodies, it had to be renatured. Isolated and purified inclusion bodies were modified under denatured conditions with glutathione and then dissolved in 6 M guanidine⋅HCl, 20 mM EDTA, pH 4.5. Refolding was done by a dilution of the protein solution into a large volume of refolding buffer: 50 mM Tris/HCl pH 8.0, 500 mM arginine, 1 mM EDTA, 0.5 mM cysteine. The preparation was kept at 4 °C for 2 days. The refolding solution was concentrated and dialyzed prior to a 1st chromatography. Zymogen chymase could be obtained by chromatography on Ni-NTA followed by a gel filtration. Enzymatically active chymase was obtained by cleaving off the 6xHis tag with enterokinase, whereas the zymogen form was further purified without enterokinase treatment. Both proteins were chromatographed on Superdex 75 in 50 mM MES, 150 mM NaCl, 1 mM TCEP, 10% glycerol at pH of 5.5. Finally, as shown by N-terminal sequencing and sodium dodecyl sulfate polyacrylamide gel electrophoresis, >98% pure protein was obtained. The purified proteins were monomeric as detected by analytical ultracentrifugation. Activated chymase was highly active in a fluorometric assay. The concentrations for the active and the zymogen protein were 450 µg/ml and 405 µg/ml, respectively.
Buffers
The protein was dissolved in an MES buffer (50 mM MES pH 5.5, 150 mM NaCl, 1 mM TCEP, 10% glycerol). The immobilization buffer was 10 mM acetic acid pH 5.5. The running buffer was 10 mM HEPES pH 7.4, 150 mM NaCl, 3 mM EDTA, 0.005% Tween 20, whereas the fluorescence titration buffer was 50 mM Tris pH 7.8, 150 mM NaCl, 1 mM TCEP.
Reference compounds
For the binding experiments, we used 5 reference compounds (Ref I to Ref V) with different molecular weights. All of these reference compounds are active site binders.
Fragment library
Compounds were selected from an internal Roche library containing about 149,000 fragments and from several libraries of external suppliers (BioNet, Maybridge, Fluka, Sigma-Aldrich, etc.) with a further 76,000 fragments. Criteria to select the compounds considered molecular weight, number of hydrogen bonds both as acceptors and as donors, number of rotatable bonds, and predicted log P values.
The fragment library itself consists of 2 sublibraries for which different criteria were applied. The filter applied for the 1st sublibrary was based on the rule of 3 reported by Congreve and others 19 to evaluate lead likeness. This is a modification of Lipinski's rule of 5 for drug likeness. 20, 21 The 2nd sublibrary, with medium-sized fragments, was generated using the less stringent criteria of the Lipinski's rule of 5. From all this filtration, a fragment library was set up containing a final 2226 compounds dissolved as 10 mM solution in DMSO.
Immobilization of protein
The proteins were immobilized on a CM5 sensor chip by amide coupling chemistry. The carboxylic acid groups in the adlayer were first activated by contacting them with a mixture of carbodiimide (750 mg/ml) and N-hydroxysuccinimide (115 mg/ml). The activated surface was then contacted with the protein solution at a concentration of 50 µg/ml. Approximately 6000 response units (RUs) of protein were immobilized, corresponding to a surface protein density of 6 ng/mm 2 . Typically, the 3 spots of the S51 instrument were used as follows: 1 spot with active chymase, a 1st reference spot with zymogen, and a 2nd reference spot with uncoated dextran.
Determination of the amount of active protein
Assuming linearity between molecular weight and refractive index, the percentage of active protein immobilized could be estimated from the saturation response of a reference compound according to equation 1.
R max is the saturation signal determined for the reference, R prot is the signal measured for the amount of immobilized protein [RU], and MW comp and MW prot are the respective molecular weights of reference compound and protein.
Binding experiments to test the binding activity of the immobilized protein
The ligand-binding activity of the immobilized proteins was investigated with 2 known reference inhibitors, Ref I and Ref II. Primary sample solutions were prepared by diluting the DMSO stock solutions into the running buffer. Starting from the primary solutions, further dilutions were prepared on the Biacore instrument. Binding experiments were performed by injecting the solutions into the instrument over all channels in parallel (i.e., channels with active chymase, reference channel with zymogen, and reference channel with uncoated dextran). The timedependent binding curves were monitored simultaneously. The flow rate was 40 µl/min. The surfaces were regenerated after each binding experiment by washing the surface with the running buffer. Kinetic rate constants and equilibrium dissociation constants (KD) were determined based on a 1:1 kinetic model using fitting procedures supplied by the instrument manufacturer (Biacore). Reference compound Ref II with its very fast kinetics and a KD value of ∼10 µM was used during all screenings at a saturation concentration of 100 µM.
Sample preparation for screening
Samples are obtained as 10 mM solution in a 384-well plate format. Two microliters of the DMSO samples were transferred into 96-well plates using a CiByWell Instrument equipped with a 96 pipette head. The 2-µl DMSO solutions were then diluted with HEPES buffer using a Multidrop instrument. The plates were then covered with a foil and mixed for 10 min on a shaker.
Sample preparation for competition assays
Stock solutions were prepared in the same way as the solutions used for screening. Single compound solutions were prepared by diluting the stock solution by a factor of 2 with running buffer. Mixtures were prepared by mixing the 2 stock solutions in a 1:1 ratio. These operations were performed on a Tecan pipettor.
Binding experiments during screening
For the screening, 10-mM compound solutions in DMSO were dispensed into the running buffer to obtain aqueous fragment solutions containing 2% DMSO. These solutions were injected over the protein sensor surface for 1 min. The flow rate was 40 µl/min, and after every 10 injections, the reference compound Ref II was injected as a control. This control measurement was performed to check both the stability and ligand-binding activity of the immobilized proteins during a screen. All screenings were performed at 25 °C.
Two 96-well plates with 192 fragments and 16 control samples were screened per day. Regeneration of the surfaces between subsequent binding experiments was achieved by washing the surface extensively (30 s) with the running buffer plus 10% DMSO. To improve the quality of the initial screening data and to decrease the false-positive rate, the fragments were routinely screened in duplicate, always at 200 µM. Sensor responses were taken during each injection after a contact interval of 30 s. Report points were used for analysis. They were corrected for refractive index change using S51 Biacore software. The final responses were obtained by subtracting the corrected responses measured on the reference spot from the corrected responses from the measuring spot. Both signals were previously referenced against the uncoated dextran surface.
Positive hits were selected based on 2 criteria. The 1st was an affinity and the 2nd a selectivity criterion. Positive compounds at the given concentration generated an SPR signal that was larger than 3 times the standard deviation of the negative control. For ranking of the positive hits, the KD value could be estimated using equation 2 derived from the Langmuir adsorption isotherm.
R max, R, and C correspond to the normalized saturation response of the reference compound, the normalized response of the test compound, and the concentration of the test solution, respectively. Equation 2 allows estimation of KD in only a limited range, that is, for KD values that are relatively close to the screening concentration (0.1  KD < c < 10  KD). A selectivity factor was calculated by dividing the response of a given compound with the active protein by that obtained with the zymogen. A positive hit should not only fulfill the above affinity criterion but also have a selectivity factor >2.
Robustness of the screening
To evaluate and validate the quality of HTS assays, the Z′ factor introduced by Zhang and others 22 was calculated according to equation 3:
σ and µ are the standard deviation and the mean of the assay response, respectively. The indices s and b denote the positive (maximum assay response) and the negative (assay response in the absence of binding) control, respectively. The Z′ factor is a measure of the quality or power of the HTS assay. It compares the variations (3σ S + 3σ b ) of the assay data with the signal window (µ S -µ b ). The maximum value of the Z′ factor is 1. In this case, the standard deviations are negligible compared with the signal window. An assay with a Z′ factor >0.8 is considered as very good, and a Z′ factor >0.6 is good. For Z′ factors <0.5, the assay is not robust enough to be used for primary screening; that is, the test of compounds at 1 concentration will not lead to statistically relevant results.
Reproducibility testing
For the reproducibility testing, compounds were tested in duplicate. All of the steps, such as sample preparation, injection mode, washing procedures, and data evaluation, were included in this duplication.
Competition experiments with reference compounds
The competition experiments were performed by sequentially injecting the solution of the test compound (fragment) at 200 µM, the reference compound at saturation concentration (100 µM), and a mixture of fragment (200 µM) and reference compound (100 µM) each for 1 min. A qualitative comparison of the signals observed for test compound, reference compound, and mixture was sufficient to distinguish between site-selective and non-site-selective binders. Compounds that bound to the same binding pocket as the reference compound showed a signal for the mixture with reference compound that was identical to the signal observed for the reference compound alone. Compounds that bound independently to an alternative site showed a signal for the mixture that corresponded to the sum of the signals determined individually for the reference and the test compound alone.
Cross-competition experiments between fragments
Cross-competition experiments between fragments were performed in a similar way as the competitive assay. Instead of using a reference compound, another fragment was used to run the competition experiment. The evaluation of competitiveness was analogous to that when working with reference compound. When fragments occupied different pockets, the response observed for the mixture was the sum of the 2 individual responses observed for the fragments. Because saturation was seldom reached with low-affinity fragments, the response observed in the case of competition (binding to the same binding pocket) was given by the sum of the fractional occupancies (FO) of both compounds. Theoretically, such fractional occupancies and therefore the expected signal of the mixture of the 2 compounds can be calculated using equations 4.
KD A and KD B are the equilibrium dissociation constants of the competing compounds, and C A and C B are the respective concentrations. A more detailed discussion of this equation is given in the Results section.
Fluorescence quenching experiment
Binding experiments in solution were carried out by fluorescence titration at 20 °C with reference compound Ref I. The protein concentration was 0.89 µM in the fluorescence titration buffer. Tryptophan fluorescence of the protein, excited at 280 nm, was recorded at 340 nm. Small aliquots of known concentration of compound Ref I, dissolved in DMSO, were added to the protein solution and each time the fluorescence intensity was measured. These fluorescence intensities, corrected for ligand adsorption, 23 were plotted against the total ligand concentration and fitted with a 4-parameter sigmoidal function. The KD value was obtained applying the law of mass action. 24
X-ray crystallography
Crystals of chymase were grown under standard conditions in the presence of ligand at 10-mM concentration or at saturation. Crystals were flash frozen and measured at the Swiss Light Source at the Paul Scherrer Institute, Villingen, Germany. Data were collected to a resolution of 1.75 Å or better.
RESULTS
Binding of reference compound monitored by Biacore
Binding experiments were generally performed with an amount of immobilized protein that corresponds to 6000 RU. (Figure 1, top, left) .
The (Figure 2, right) . The good linearity observed indicated a high homogeneity of the surface with respect to the protein-binding activity. It also indicated that a specific, lowaffinity binding occurs with the reference compound Ref II. This compound represented an ideal control for the ligand-binding activity of the enzyme during the fragment screen because it dissociated quickly from the surface and the regeneration interval between fragment injections could be chosen to be very short. This sped up the whole screening process.
Fluorescence
As a control, the affinity of reference compounds was also tested in homogeneous solution by an intrinsic fluorescence titration experiment. Figure 3 shows a typical titration curve using reference compound Ref I. The measured fluorescence intensities, corrected for ligand absorption, were unambiguously fitted to a sigmoidal curve (solid line). Assuming a 1:1 binding model, a KD value of 300 nM was obtained, in agreement with the value of 290 nM determined by SPR. Thus, the immobilization did not influence the protein ligand-binding activity.
Determination of Z′ factor
Z′ factors were determined for 4 reference compounds with different molecular weights. They were obtained by alternatively injecting solutions from a reference compound at saturation concentration and from a negative control. The solutions were prepared in the same way as the sample solutions during the screening by mixing the DMSO stock solution with the buffer solution. The Z′ factors were calculated from the monitored responses using equation 3. As expected from this equation, they are highly dependent on the saturation signal of the reference compound, which is related to the molecular weight of the compound. The Z′ factors are summarized in Table 1 . phase. The responses measured for the zymogen are shown as white bars and the responses from the active protein as black bars. The responses measured for the 8 reference compounds injected as control during the run are marked with a black star. The black horizontal dashed line indicates 3 times the average noise level determined from responses observed for the negative controls. The low variation in the signal of the reference compound shows, on one hand, the high stability of the protein during the screen and, on the other hand, the high reproducibility of the assay. Comparison of white and black bars of the reference compound indicates that at the selected concentration, the selectivity factor is in the range of 8. The selection criteria for positive hits were based on the affinity and the selectivity of binding. In a 1st filtering, compounds were selected only if their affinity led to a sensor response that corresponded to 3 times the noise level ( Fig. 5, black dashed line) . It can be seen that only a few compounds from this representative set fulfilled this affinity criterion. This number was further reduced when the selectivity filter was applied. Applying a very loose filter, only compounds with a selectivity factor less then 2 were eliminated from the compounds that passed the affinity filter. Applying the affinity and selectivity criteria to the screening data in Figure 5 a. Reference compounds were obtained by injecting alternatively solutions from a reference compound at saturation concentration and from a negative control. The Z′ factors were calculated from the monitored responses using equation 3. As expected from this equation, they are highly dependent on the saturation signal of the reference compound, which is related to the molecular weight of the compound. b. Z′ factors calculated using molecular weight-normalized sensor responses. a sensogram that indicates nonequilibrium behavior. 25 A total of 734 compounds (33%) showed a sensor response that was higher than the threshold (i.e., higher than 3 times the standard deviation of the negative control). By applying the selectivity filter, the number of hits was reduced to 180 fragments (∼8%). The interpretation of such a finding is complex and completely different from the situation described in the 1st experiment of Figure 6 . Whereas a competing reference compound with high affinity that saturated all the binding sites was used in the 1st experiment (competition), the competitors in the 2nd experiment (cross-competition) were 2 fragments of low affinity. For these fragments, there is neither full occupancy nor full displacement of one compound by the other. The theoretical background to estimate the expected occupancies of binding sites by competing compounds for such a situation is given by equations 4. Figure 7 shows graphically the results obtained by applying these equations to hypothetical KD values and concentrations. In the case of noncompetition (i.e., in the case of independent binding sites for each of the compounds), the occupancy of the binding sites, when injecting the mixture of both compounds, is always the sum of the individual occupancies. This holds also for the respective responses. It is therefore straightforward to conclude that compound Ref I occupies a different binding site than B and D because the response of their mixtures corresponds always to the sum of the individual responses.
Reproducibility testing
Fragment-based screening
Results of competition experiments
In the case of competition between compounds of similar affinity and equal concentration, the occupancy of the binding sites by one of the components is heavily influenced by the presence of the other. This is clearly seen in Figure 7 Table 2 contains the measured responses, the KD values, the R max , and the concentrations to calculate the expected responses for different fragment mixtures. The estimation of the response for the signal of the mixture A+C gives a value of 27 RU for competition and a value of 43 RU for noncompetition, as shown in Figure 6 (bottom) by the dark gray bar with stars and the dark gray bar, respectively. The result is clearly in favor of competition and identical binding sites for A and C. From the 180 fragments found by the affinity and selectivity filter, 80 compounds showed such a competitive behavior. A statistically relevant correlation between degree of selectivity and competition behavior could not be extracted from these data. Besides having confirmed the hits from the primary screen by competitive experiments, the fragment hits were also analyzed by X-ray crystallography. Of the first 36 crystals measured, 12 showed clear ligand electron density. Figure 8 shows 2 examples.
DISCUSSION
Three-dimensional structure information, most often extracted from X-ray structure analysis, is of utmost importance in fragment-based drug-discovery approaches. It is needed for the selection of the best fragments with respect to orientation in the binding pocket and for the determination of suitable exit vectors to start chemistry. Because X-ray structure analysis is a time-and material-consuming process, methods are needed to reduce the number of potential candidates from fragment libraries for X-ray trials. The present work introduces a fragment-screening approach that makes extensive use of several SPR-based binding assays. This leads to a reduction of the number of candidates from the library to 3.6%. A direct binding assay is used to determine the affinity of the fragments for active chymase. A 2nd direct binding assay that is performed in parallel with the inactive zymogen is used to test for active site-specific binding. This assay further reduced the number of candidates to 8%. Active site specificity of fragment binding is further confirmed with a competition assay using a competitor compound that fits and occupies the whole active site. Only 44% of the remaining compounds (3.6% of the total) passed this competition filter. The result of such extensive SPR work is a set of compounds with a relatively high positive hit rate (30%) in crystallization trials. The SPR screening cascade has proven to be an efficient tool to select fragments worth being submitted to crystallization trials.
A highly robust and reliable binding assay is a prerequisite for success of such SPR-driven filtering. In this work, the Z′ factor has been taken as a possible measure. During HTS campaigns, Z′ factors (see equation 3) are often used to check stability of the assay and goodness of the screen. Although Z′ factors used in SPR have some fundamental differences to Z′ factors used in HTS (see below), the use of such Z′ factors is also highly recommended for SPR screens, because it considers all relevant parameters that indicate instabilities of an assay during a screen such as change in the standard deviation of positive and negative controls and change in the ligand-binding activity of the immobilized protein. It represents therefore a single measure to compare assay quality and stability from plate to plate.
In contrast to Z′ factors in HTS, the Z′ factor of SPR-based binding assays should not be taken as an absolute quality criterion to compare different assays because Z′ factors of SPR binding assays are dependent on the saturation sensor response and hence from the optical mass of the compounds taken as references. This optical mass is roughly correlated with the molecular mass of compounds of similar elemental composition. Over the molecular weight range (451 Da ≥ MW ≥ 161 Da) covered by our reference compounds (Ref II to Ref IV) , the Z′ factor changes from nearly 0.9 (450 Da) to about 0.5 (161 Da). Table 1 shows that Z′ factors become similar within ±10% when using molecular weight-normalized sensor responses for the saturation signal of the positive control. To become a meaningful measure of quality that is comparable, assays and screens such Z′ factors should be adapted to the average molecular weight of the compound library screened. The average molecular weight of our fragment library is about 215 Da, and the relevant Z′ factor is about 0.77. This value indicates that testing the compounds of this library with this assay leads on average to statistically relevant results that enable differentiation of positives and negatives. However, one should still keep in mind that libraries have a certain molecular weight distribution and that statistical relevance of SPR-assay results changes with the molecular weight of the tested compounds. Figure 9 shows schematically the molecular weight distribution of our fragment library and the Z′ factors that are relevant for the different molecular weight segments. These Z′ factors have been estimated based on the molecular weight dependence shown in Table 1 . The figure shows that, according to the Z′ factor, no statistically relevant results can be expected for 7% of our library with MW <140 Da. In addition to quality control, the Z′ factor can be used to determine the minimum molecular weight and the percentage of compounds of a given library for which statistically relevant data could be expected. This discussion of the Z′ factor also points at which parameters have to be optimized to increase the Z′ factor for compounds of the low-molecular-weight segment of a library. Often, the standard deviations of positive and negative controls in the numerator of equation 3 are quite constant from assay to assay because they are mainly determined by instrumental parameters (temperature stability, fluidic system, etc.) and buffer conditions. Z′ factor and thus assay quality can therefore be improved by making the denominator in equation 3 larger (i.e., by optimizing the immobilization procedure for maximum response). The theoretically calculated ligand-binding activity of the protein (66% of the immobilized protein active) is already quite high, and room for improvement along this line is limited for this assay. Protein-engineering techniques would be required that enable directed immobilization and 100% preservation of binding activity of the protein upon immobilization.
Beside assay robustness and quality, testing of primary hits with assays enabling selectivity filtering is another important FIG. 8 . Examples of fragment-binding modes determined by X-ray crystallography. (Top) A typical bound fragment: The phenyl group is inserted into the S1 pocket, and the keto oxygen is in the oxyanion hole. The electron density determined at 1.73 Å resolution is contoured at 1.0 rms. It may be seen that the ester group is largely degraded to the acid. (Bottom) A smaller fragment bound in the S1 pocket. The electron density determined at 1.0 Å resolution is contoured at 2.0 rms. Although the binding mode is extremely well determined, there appears to be no directed interaction, such as a hydrogen bond, which determines the precise position. All of the fragment structures determined show aromatic groups in S1, and many have acid groups or oxygen atoms in the oxyanion hole. This agrees with the known preference of chymase to cleave peptides after tyrosine, phenylalanine, or tryptophan. . 9 . Molecular weight distribution of the fragment library and the Z′ factor that are relevant for the different molecular weight segments. These Z′ factors have been estimated based on the molecular weight dependence shown in Table 1 .
prerequisite for efficient selection of candidates from fragment libraries for crystallization trials. Affinity filtering based on responses monitored at a single concentration would have eliminated in the present case only 67% of the compounds as negatives. Especially in this case, where protein/ligand crystals had to be prepared by co-crystallization, the remaining 730 compounds would have been by far too many. Only the application of the 1st selectivity filter using the inactive zymogen as a reference protein and the selectivity filter using competition experiments reduced the library to a manageable number of 80 compounds. A hit rate of 30% for such crystallization experiments is excellent, considering that there are severe differences in buffer conditions between SPR binding experiments and crystallization experiments.
In this work, the potential of competition experiments is further exploited by performing cross-competition experiments between fragments. In the present case, 2 pockets that are located in the active site of the protein, but that can bind independently different fragments, have been identified by cross-competition experiments and by crystallography. Finding such fragments can significantly influence the follow-up strategy of a fragment screen. Such independently binding fragments could in principle be directly linked to give larger high-affinity compounds. In the absence of such independently binding fragments, a "fragment evolution" strategy has to be applied.
In summary, the present work shows the efficient use of a SPR-based screening cascade for the selection of fragments from a library for crystallization trials. As already mentioned in the introduction, many other techniques (NMR, mass spectroscopy, and thermal shift experiments) described in the literature are suitable for fragment screenings. The main advantages of the SPR technology compared with others reside in low material consumption and relatively high throughput.
Only a few micrograms of protein were needed for immobilization on the surface. Such a surface could be used for up to 600 binding experiments.
